The numbers of SARS-CoV-2 infected cases are soaring in India. While the rest of us move into unlock mode, millions of pregnant women in the country are still in an extended lockdown.
As per UNICEF statistics, India faces the world’s largest burden of COVID-19 pregnancies as 20.1 million births are expected since the COVID-19 pandemic was declared. This is more than China, which comes second to India, with 13 million births expected. A much-neglected aspect of the COVID-19 pandemic is the psychological stress during pregnancy and its risk on the development of the baby (neurodevelopmental effects on the offspring – published in Journal of Psychosomatic Obstetrics and Gynaecology in May 2020).
Pregnant women do not appear more likely to contract the infection than the general population. However, pregnancy itself alters the body’s immune system and response to viral infections in general, which can occasionally be related to more severe symptoms and this will be the same for COVID-19.
Reported cases of COVID-19 pneumonia in pregnancy are milder and with good recovery.
Pregnant women with heart disease are at the highest risk (congenital or acquired).
Dr. Shivani Sachdev Gour was live 2 webinars with eminent faculty COVID_19 guidelines and medicolegal queries. Next one with Fogsi Endometriosis Committee Dr. Asha Rao mam with eminent International speakers.
Live presentation on Laparoscopy: in anticipation of a substantial amount of operations in the near future of asymptomatic COVID 19 carriers and infected patients the guidelines by SAGES and EAES of the Indian Association of Gynaecological Endoscopists (IAGE) and our local modification. https://www.youtube.com/watch?v=x1y2u6Ykg10
PRP Platelet Rich Plasma in Infertility IVF Recurrent Implantation failure Premature Ovarian failure and Gynaecology. Platelet-rich plasma (PRP) has become popular as a non-operative treatment option for a broad spectrum of medical disorders. There is a reasonable amount of data that warrant continued research in PRP but currently, its role in clinical practice is not completely defined. Prior to its use, special consent is required after an honest and open discussion with the patient as well-controlled human studies are lacking.